Home » Market News » DirectorsTalk Highlights » Precision medicine
Nanoco Group PLC

Precision medicine

Bringing patient and treatment closer together is becoming faster, personalised and more technical.

Innovation has already revolutionised medicine in the past few decades. Break-through drugs have made HIV/AIDS survivable and hepatitis C potentially curable. Meanwhile, a range of new technologies from immunotherapy to biorobotics are already making the notion of precision and personalised medicine a reality.

In the years to come, innovations in nanotechnology, biotechnology, information technology and cognitive science (NBIC) promise to change the way patients are diagnosed and healthcare is delivered. A number of potential cross-industry applications will make it easier to develop drugs more efficiently and identify patients for clinical trials more precisely.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.